Michael L O'Byrne1, Kevin F Kennedy2, Jonathan J Rome3, Andrew C Glatz4. 1. Division of Cardiology, Children's National Health System and Department of Pediatrics, George Washington University School of Health Sciences, Washington, DC, USA. Electronic address: obyrnem@email.chop.edu. 2. Mid America Heart Institute St. Luke's Health System, Kansas City, MO, USA. 3. Division of Cardiology, The Children's Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. 4. Division of Cardiology, The Children's Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Center for Pediatric Clinical Effectiveness, Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA, USA.
Abstract
Practice variation is a potentially important measure of healthcare quality. The IMPACT registry provides a representative national sample with which to study practice variation in trans-catheter interventions for congenital heart disease. METHODS: We studied cases for closure of atrial septal defect (ASD) and patent ductus arteriosus (PDA) in IMPACT between January 1, 2011, and September 30, 2015, using hierarchical multivariate models studying (1) the distribution of indications for closure and (2) in patients whose indication for closure was left (LVVO) or right ventricular volume overload (RVVO), the factors influencing probability of closure of a small defect (either in size or in terms of the magnitude of shunt). RESULTS: Over the study period, 5233 PDA and 4459 ASD cases were performed at 77 hospitals. The indications for ASD closure were RVVO in 84% and stroke prevention in 13%. Indications for PDA closure were LVVO in 57%, endocarditis prevention in 36%, and pulmonary hypertension in 7%. There was statistically significant variability in indications between hospitals for PDA and ASD procedures (median rate ratio (MRR): 1.3 and 1.1; both P<.001). The proportion of cases for volume overload with a Qp:Qs <1.5:1 decreased with increasing PDA and ASD procedural volume (P=.04 and 0.05). For ASD, the proportion was higher at hospitals with a larger proportion of adult cases (P=.0007). There was significant variation in practice in the risk of closing PDA <2 mm for LVVO (MRR: 1.4, P<.001). CONCLUSION: There is measurable variation in transcatheter closure of PDA and ASD. Further research is necessary to study whether this affects outcomes or resource utilization.
Practice variation is a potentially important measure of healthcare quality. The IMPACT registry provides a representative national sample with which to study practice variation in trans-catheter interventions for congenital heart disease. METHODS: We studied cases for closure of atrial septal defect (ASD) and patent ductus arteriosus (PDA) in IMPACT between January 1, 2011, and September 30, 2015, using hierarchical multivariate models studying (1) the distribution of indications for closure and (2) in patients whose indication for closure was left (LVVO) or right ventricular volume overload (RVVO), the factors influencing probability of closure of a small defect (either in size or in terms of the magnitude of shunt). RESULTS: Over the study period, 5233 PDA and 4459 ASD cases were performed at 77 hospitals. The indications for ASD closure were RVVO in 84% and stroke prevention in 13%. Indications for PDA closure were LVVO in 57%, endocarditis prevention in 36%, and pulmonary hypertension in 7%. There was statistically significant variability in indications between hospitals for PDA and ASD procedures (median rate ratio (MRR): 1.3 and 1.1; both P<.001). The proportion of cases for volume overload with a Qp:Qs <1.5:1 decreased with increasing PDA and ASD procedural volume (P=.04 and 0.05). For ASD, the proportion was higher at hospitals with a larger proportion of adult cases (P=.0007). There was significant variation in practice in the risk of closing PDA <2 mm for LVVO (MRR: 1.4, P<.001). CONCLUSION: There is measurable variation in transcatheter closure of PDA and ASD. Further research is necessary to study whether this affects outcomes or resource utilization.
Authors: Michael Farias; Kevin G Friedman; Andrew J Powell; Sarah D de Ferranti; Audrey C Marshall; David W Brown; Thomas J Kulik Journal: Pediatrics Date: 2012-06-04 Impact factor: 7.124
Authors: Kevin G Friedman; Rahul H Rathod; Michael Farias; Dionne Graham; Andrew J Powell; David R Fulton; Jane W Newburger; Steven D Colan; Kathy J Jenkins; James E Lock Journal: Congenit Heart Dis Date: 2010 Jul-Aug Impact factor: 2.007
Authors: Michael L O'Byrne; Russell T Shinohara; Elena K Grant; Joshua P Kanter; Matthew J Gillespie; Yoav Dori; Jonathan J Rome; Andrew C Glatz Journal: Am Heart J Date: 2017-07-19 Impact factor: 4.749
Authors: Michel Komajda; Pablo Lapuerta; Nancy Hermans; José Ramon Gonzalez-Juanatey; Dirk J van Veldhuisen; Erland Erdmann; Luigi Tavazzi; Philip Poole-Wilson; Claude Le Pen Journal: Eur Heart J Date: 2005-04-12 Impact factor: 29.983
Authors: Ravi S Hira; Kevin Kennedy; Vijay Nambi; Hani Jneid; Mahboob Alam; Sukhdeep S Basra; P Michael Ho; Anita Deswal; Christie M Ballantyne; Laura A Petersen; Salim S Virani Journal: J Am Coll Cardiol Date: 2015-01-20 Impact factor: 24.094
Authors: Peter Engelfriet; Jan Tijssen; Harald Kaemmerer; Michael A Gatzoulis; Eric Boersma; Erwin Oechslin; Erik Thaulow; Jana Popelová; Philip Moons; Folkert Meijboom; Luciano Daliento; Rafael Hirsch; Valérie Laforest; Ulf Thilén; Barbara Mulder Journal: Eur Heart J Date: 2006-01-09 Impact factor: 29.983
Authors: Michael L O'Byrne; Matthew J Gillespie; Kevin F Kennedy; Yoav Dori; Jonathan J Rome; Andrew C Glatz Journal: Catheter Cardiovasc Interv Date: 2016-05-18 Impact factor: 2.692
Authors: William R Lewis; Eric D Peterson; Christopher P Cannon; Dennis M Super; Kenneth A LaBresh; Kathleen Quealy; Li Liang; Gregg C Fonarow Journal: Arch Intern Med Date: 2008-09-08
Authors: Michael L O'Byrne; Marisa E Millenson; Connor B Grady; Jing Huang; Nicolas A Bamat; David A Munson; Lihai Song; Yoav Dori; Matthew J Gillespie; Jonathan J Rome; Andrew C Glatz Journal: Am Heart J Date: 2019-08-17 Impact factor: 4.749
Authors: Michael L O'Byrne; Kevin F Kennedy; James M Steven; Kevin D Hill; Reid C Chamberlain; Marisa E Millenson; Christopher L Smith; Yoav Dori; Matthew J Gillespie; Jonathan J Rome; Andrew C Glatz Journal: JACC Cardiovasc Interv Date: 2021-02-22 Impact factor: 11.195
Authors: Michael L O'Byrne; Lihai Song; Jing Huang; David J Goldberg; Monique M Gardner; Chitra Ravishankar; Jonathan J Rome; Andrew C Glatz Journal: Pediatr Cardiol Date: 2021-02-02 Impact factor: 1.655
Authors: Michael L O'Byrne; Andrew C Glatz; Jennifer A Faerber; Roopa Seshadri; Marisa E Millenson; Lanyu Mi; Russell T Shinohara; Yoav Dori; Matthew J Gillespie; Jonathan J Rome; Steven M Kawut; Peter W Groeneveld Journal: J Am Heart Assoc Date: 2019-05-07 Impact factor: 5.501
Authors: Michael L O'Byrne; Kevin F Kennedy; Natalie Jayaram; Lisa J Bergersen; Matthew J Gillespie; Yoav Dori; Jeffrey H Silber; Steven M Kawut; Jonathan J Rome; Andrew C Glatz Journal: J Am Heart Assoc Date: 2019-10-17 Impact factor: 5.501
Authors: Justin H Berger; Feiyan Chen; Jennifer A Faerber; Michael L O'Byrne; Julie A Brothers Journal: Am Heart J Date: 2020-10-24 Impact factor: 4.749
Authors: Ho Xuan Tuan; Phan The Phuoc Long; Vu Duy Kien; Le Manh Cuong; Nguyen Van Son; Robert Dalla-Pozza Journal: J Cardiovasc Dev Dis Date: 2019-12-27